These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3280346)

  • 1. Determination of intermediates, products and cleavage site in the reaction between plasminogen activator inhibitor type-2 and urokinases.
    Kiso U; Kaudewitz H; Henschen A; Astedt B; Kruithof EK; Bachmann F
    FEBS Lett; 1988 Mar; 230(1-2):51-6. PubMed ID: 3280346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and characterization of a plasminogen activator inhibitor from the histiocytic lymphoma cell line U-937.
    Kruithof EK; Vassalli JD; Schleuning WD; Mattaliano RJ; Bachmann F
    J Biol Chem; 1986 Aug; 261(24):11207-13. PubMed ID: 3090045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An inhibitor of plasminogen activation from human placenta. Purification and characterization.
    Wun TC; Reich E
    J Biol Chem; 1987 Mar; 262(8):3646-53. PubMed ID: 3102492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator-specific inhibitors produced by human monocytes/macrophages.
    Wohlwend A; Belin D; Vassalli JD
    J Exp Med; 1987 Feb; 165(2):320-39. PubMed ID: 2434595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identity between the placental protein PP10 and the specific plasminogen activator inhibitor of placental type PAI-2.
    Kiso U; Henschen A; Bohn H; Heimburger N; Radtke KP; Lecander I; Astedt B
    Biochim Biophys Acta; 1991 May; 1074(1):74-8. PubMed ID: 2043683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and partial characterization of a specific plasminogen activator inhibitor in human chondrocyte cultures.
    Yamada H; Stephens RW; Nakagawa T; McNicol D
    J Biochem; 1988 Dec; 104(6):960-7. PubMed ID: 3149640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urokinase-type plasminogen activator/type-2 plasminogen-activator inhibitor complexes are not internalized upon binding to the urokinase-type-plasminogen-activator receptor in THP-1 cells. Interaction of urokinase-type plasminogen activator/type-2 plasminogen-activator inhibitor complexes with the cell surface.
    Ragno P; Montuori N; Rossi G
    Eur J Biochem; 1995 Oct; 233(2):514-9. PubMed ID: 7588796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction of streptokinase.plasminogen activator complex, tissue-type plasminogen activator, urokinase and their acylated derivatives with fibrin and cyanogen bromide digest of fibrinogen. Relationship to fibrinolytic potency in vitro.
    Cassels R; Fears R; Smith RA
    Biochem J; 1987 Oct; 247(2):395-400. PubMed ID: 3122725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of a specific placental plasminogen activator inhibitor by monoclonal antibody and its complex formation with plasminogen activator.
    Astedt B; Lecander I; Brodin T; Lundblad A; Löw K
    Thromb Haemost; 1985 Feb; 53(1):122-5. PubMed ID: 3922076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human endothelial cells produce a plasminogen activator inhibitor and a tissue-type plasminogen activator-inhibitor complex.
    Philips M; Juul AG; Thorsen S
    Biochim Biophys Acta; 1984 Nov; 802(1):99-110. PubMed ID: 6435688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Covalent molecular weight approximately 92 000 hybrid plasminogen activator derived from human plasmin amino-terminal and urokinase carboxyl-terminal domains.
    Robbins KC; Tanaka Y
    Biochemistry; 1986 Jun; 25(12):3603-11. PubMed ID: 2941075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a macrophage-derived plasminogen-activator inhibitor. Similarities with placental urokinase inhibitor.
    Chapman HA; Stone OL
    Biochem J; 1985 Aug; 230(1):109-16. PubMed ID: 2932100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the cyanogen-bromide-2 fragment of fibrinogen on plasminogen activation by single-chain urokinase-type plasminogen activator.
    Kirchheimer JC; Resch I; Christ G; Wojta J; Binder BR
    Eur J Biochem; 1987 Jul; 166(2):393-7. PubMed ID: 3609016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A plasminogen activator inhibitor-2 from a promyelocytic leukemia cell line, PL-21, binds to the carboxy-terminal chain of plasminogen activators.
    Takeuchi T; Niiya K; Kubonishi I; Miyoshi I
    Thromb Haemost; 1990 Apr; 63(2):259-64. PubMed ID: 2363126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A hybrid protein of urokinase growth-factor domain and plasminogen-activator inhibitor type 2 inhibits urokinase activity and binds to the urokinase receptor.
    Ballance DJ; Marshall JM; Cottingham IR; Steven J; Berry SJ; Cederholm-Williams SA; Goodey AR; Courtney M
    Eur J Biochem; 1992 Jul; 207(1):177-83. PubMed ID: 1321039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of the reaction between urokinase and an inhibitor of fibrinolysis from placental tissue.
    Christensen U; Holmberg L; Bladh B; Astedt B
    Thromb Haemost; 1982 Aug; 48(1):24-6. PubMed ID: 6813991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of tissue type and urokinase type plasminogen activators as well as plasminogen activator inhibitor type-1 and type-2 in human and rhesus monkey placenta.
    Hu ZY; Liu YX; Liu K; Byrne S; Ny T; Feng Q; Ockleford CD
    J Anat; 1999 Feb; 194 ( Pt 2)(Pt 2):183-95. PubMed ID: 10337950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Processing of complex between urokinase and its type-2 inhibitor on the cell surface. A possible regulatory mechanism of urokinase activity.
    Ragno P; Montuori N; Vassalli JD; Rossi G
    FEBS Lett; 1993 Jun; 323(3):279-84. PubMed ID: 8388810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanism of the reaction between human plasminogen-activator inhibitor 1 and tissue plasminogen activator.
    Lindahl TL; Ohlsson PI; Wiman B
    Biochem J; 1990 Jan; 265(1):109-13. PubMed ID: 2105714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human articular cartilage contains an inhibitor of plasminogen activator.
    Yamada H; Stephens RW; Nakagawa T; McNicol D
    J Rheumatol; 1988 Jul; 15(7):1138-43. PubMed ID: 3139880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.